Specialty Pharmacy

The aging HIV population presents challenges to health care providers.

Officials with the FDA have approved ibalizumab-uiyk (Trogarzo, TaiMed Biologics), the first antiretroviral medication for adults with HIV who cannot be successfully treated with other therapies.

Mylan will reduce the wholesale acquisition costs of Smyfi Lo and Cimduo, which are both combination therapies for HIV.

Targeting an energy-related molecule could prevent the onset of autoimmune diseases.

A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.

HIV packages a key viral protein in exosomes to transport throughout the body.

An enzyme blockade could assist remyelination in patients with peripheral nerve damage.

Top news of the day from across the health care landscape.

New study findings suggest that more at-risk individuals should take pre-exposure prophylaxis to prevent HIV.

In an effort to evaluate whether switching from a reference biologic to a biosimilar could lead to altered clinical outcome, a research team, led by Hillel Cohen, PhD, conducted a systematic literature review of all available switching studies.

Daclizumab (Zinbryta) may cause brain inflammation among patients with relapsing multiple sclerosis.

Biologic drug demonstrates efficacy in moderate-to-severe asthma.

Patients with colon cancer who regularly consumed tree nuts had a 46% improvement in disease-free survival.

Shiela Arquette, RPh, BS Pharm, Executive Director, National Association of Specialty Pharmacy, discusses how the organization has fought against direct and indirect remuneration fees on behalf of specialty pharmacies.

Current treatments for neurofibromatosis tumors may result in drug resistance.

Top news of the day from across the health care landscape.

The authors of the study acknowledged that there is much more to be understood about the factors that affect adolescents and young adults at high risk for contracting or transmitting HIV.

We all make important interventions as pharmacists, but we don’t make front page headlines.

Increase in Merkel cell carcinoma cases outpaces the rate of melanoma.

Top news of the week from Specialty Pharmacy Times.

The US Preventive Services Task Force recommends against ovarian cancer screening.

Top news of the day from across the health care landscape.

March is multiple sclerosis awareness month.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

ERK inhibitors may increase the efficacy of other anti-cancer drugs.

Research highlights the need for new prostate specific antigen testing guidelines.

Ozanimod evaluated as a treatment for multiple sclerosis and inflammatory bowel disease.

Men exposed to diesel exhaust at work may increase their risk of ALS by at least 20%.

Top news of the day from across the health care landscape.

PBMs currently operate in Arkansas with no government oversight